Global Non-invasive Cancer Diagnosis Market Size, Status and Forecast 2018-2025

2018-12-07 / 3900.00 / Pharma & Healthcare / 90 Pages

Description

In 2017, the global Non-invasive Cancer Diagnosis market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global Non-invasive Cancer Diagnosis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-invasive Cancer Diagnosis development in United States, Europe and China.

The key players covered in this study
Gen-Probe Inc.
A&G Pharmaceutical
Affymetrix Inc.
Digene Corporation
Quest Diagnostics Inc.
BioView Inc.
LabCorp
AVIVA Biosciences Corporation
Precision Therapeutics

Market segment by Type, the product can be split into
Clinical Chemistry
Immunochemistry/Immunoassay
Molecular Diagnostics
Others

Market segment by Application, split into
Blood Cancer
Solid Tumors
Breast Cancer
Lung Cancer
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Non-invasive Cancer Diagnosis status, future forecast, growth opportunity, key market and key players.
To present the Non-invasive Cancer Diagnosis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Non-invasive Cancer Diagnosis are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Content

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Non-invasive Cancer Diagnosis Market Size Growth Rate by Type (2013-2025)
1.4.2 Clinical Chemistry
1.4.3 Immunochemistry/Immunoassay
1.4.4 Molecular Diagnostics
1.4.5 Others
1.5 Market by Application
1.5.1 Global Non-invasive Cancer Diagnosis Market Share by Application (2013-2025)
1.5.2 Blood Cancer
1.5.3 Solid Tumors
1.5.4 Breast Cancer
1.5.5 Lung Cancer
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Non-invasive Cancer Diagnosis Market Size
2.2 Non-invasive Cancer Diagnosis Growth Trends by Regions
2.2.1 Non-invasive Cancer Diagnosis Market Size by Regions (2013-2025)
2.2.2 Non-invasive Cancer Diagnosis Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Non-invasive Cancer Diagnosis Market Size by Manufacturers
3.1.1 Global Non-invasive Cancer Diagnosis Revenue by Manufacturers (2013-2018)
3.1.2 Global Non-invasive Cancer Diagnosis Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Non-invasive Cancer Diagnosis Market Concentration Ratio (CR5 and HHI)
3.2 Non-invasive Cancer Diagnosis Key Players Head office and Area Served
3.3 Key Players Non-invasive Cancer Diagnosis Product/Solution/Service
3.4 Date of Enter into Non-invasive Cancer Diagnosis Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Non-invasive Cancer Diagnosis Market Size by Type (2013-2018)
4.2 Global Non-invasive Cancer Diagnosis Market Size by Application (2013-2018)

5 United States
5.1 United States Non-invasive Cancer Diagnosis Market Size (2013-2018)
5.2 Non-invasive Cancer Diagnosis Key Players in United States
5.3 United States Non-invasive Cancer Diagnosis Market Size by Type
5.4 United States Non-invasive Cancer Diagnosis Market Size by Application

6 Europe
6.1 Europe Non-invasive Cancer Diagnosis Market Size (2013-2018)
6.2 Non-invasive Cancer Diagnosis Key Players in Europe
6.3 Europe Non-invasive Cancer Diagnosis Market Size by Type
6.4 Europe Non-invasive Cancer Diagnosis Market Size by Application

7 China
7.1 China Non-invasive Cancer Diagnosis Market Size (2013-2018)
7.2 Non-invasive Cancer Diagnosis Key Players in China
7.3 China Non-invasive Cancer Diagnosis Market Size by Type
7.4 China Non-invasive Cancer Diagnosis Market Size by Application

8 Japan
8.1 Japan Non-invasive Cancer Diagnosis Market Size (2013-2018)
8.2 Non-invasive Cancer Diagnosis Key Players in Japan
8.3 Japan Non-invasive Cancer Diagnosis Market Size by Type
8.4 Japan Non-invasive Cancer Diagnosis Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Non-invasive Cancer Diagnosis Market Size (2013-2018)
9.2 Non-invasive Cancer Diagnosis Key Players in Southeast Asia
9.3 Southeast Asia Non-invasive Cancer Diagnosis Market Size by Type
9.4 Southeast Asia Non-invasive Cancer Diagnosis Market Size by Application

10 India
10.1 India Non-invasive Cancer Diagnosis Market Size (2013-2018)
10.2 Non-invasive Cancer Diagnosis Key Players in India
10.3 India Non-invasive Cancer Diagnosis Market Size by Type
10.4 India Non-invasive Cancer Diagnosis Market Size by Application

11 Central & South America
11.1 Central & South America Non-invasive Cancer Diagnosis Market Size (2013-2018)
11.2 Non-invasive Cancer Diagnosis Key Players in Central & South America
11.3 Central & South America Non-invasive Cancer Diagnosis Market Size by Type
11.4 Central & South America Non-invasive Cancer Diagnosis Market Size by Application

12 International Players Profiles
12.1 Gen-Probe Inc.
12.1.1 Gen-Probe Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Non-invasive Cancer Diagnosis Introduction
12.1.4 Gen-Probe Inc. Revenue in Non-invasive Cancer Diagnosis Business (2013-2018)
12.1.5 Gen-Probe Inc. Recent Development
12.2 A&G Pharmaceutical
12.2.1 A&G Pharmaceutical Company Details
12.2.2 Company Description and Business Overview
12.2.3 Non-invasive Cancer Diagnosis Introduction
12.2.4 A&G Pharmaceutical Revenue in Non-invasive Cancer Diagnosis Business (2013-2018)
12.2.5 A&G Pharmaceutical Recent Development
12.3 Affymetrix Inc.
12.3.1 Affymetrix Inc. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Non-invasive Cancer Diagnosis Introduction
12.3.4 Affymetrix Inc. Revenue in Non-invasive Cancer Diagnosis Business (2013-2018)
12.3.5 Affymetrix Inc. Recent Development
12.4 Digene Corporation
12.4.1 Digene Corporation Company Details
12.4.2 Company Description and Business Overview
12.4.3 Non-invasive Cancer Diagnosis Introduction
12.4.4 Digene Corporation Revenue in Non-invasive Cancer Diagnosis Business (2013-2018)
12.4.5 Digene Corporation Recent Development
12.5 Quest Diagnostics Inc.
12.5.1 Quest Diagnostics Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Non-invasive Cancer Diagnosis Introduction
12.5.4 Quest Diagnostics Inc. Revenue in Non-invasive Cancer Diagnosis Business (2013-2018)
12.5.5 Quest Diagnostics Inc. Recent Development
12.6 BioView Inc.
12.6.1 BioView Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Non-invasive Cancer Diagnosis Introduction
12.6.4 BioView Inc. Revenue in Non-invasive Cancer Diagnosis Business (2013-2018)
12.6.5 BioView Inc. Recent Development
12.7 LabCorp
12.7.1 LabCorp Company Details
12.7.2 Company Description and Business Overview
12.7.3 Non-invasive Cancer Diagnosis Introduction
12.7.4 LabCorp Revenue in Non-invasive Cancer Diagnosis Business (2013-2018)
12.7.5 LabCorp Recent Development
12.8 AVIVA Biosciences Corporation
12.8.1 AVIVA Biosciences Corporation Company Details
12.8.2 Company Description and Business Overview
12.8.3 Non-invasive Cancer Diagnosis Introduction
12.8.4 AVIVA Biosciences Corporation Revenue in Non-invasive Cancer Diagnosis Business (2013-2018)
12.8.5 AVIVA Biosciences Corporation Recent Development
12.9 Precision Therapeutics
12.9.1 Precision Therapeutics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Non-invasive Cancer Diagnosis Introduction
12.9.4 Precision Therapeutics Revenue in Non-invasive Cancer Diagnosis Business (2013-2018)
12.9.5 Precision Therapeutics Recent Development

13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details


Table of Figures

List of Tables and Figures

Table Non-invasive Cancer Diagnosis Key Market Segments
Table Key Players Non-invasive Cancer Diagnosis Covered
Table Global Non-invasive Cancer Diagnosis Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Non-invasive Cancer Diagnosis Market Size Market Share by Type 2013-2025
Figure Clinical Chemistry Figures
Table Key Players of Clinical Chemistry
Figure Immunochemistry/Immunoassay Figures
Table Key Players of Immunochemistry/Immunoassay
Figure Molecular Diagnostics Figures
Table Key Players of Molecular Diagnostics
Figure Others Figures
Table Key Players of Others
Table Global Non-invasive Cancer Diagnosis Market Size Growth by Application 2013-2025 (Million US$)
Figure Blood Cancer Case Studies
Figure Solid Tumors Case Studies
Figure Breast Cancer Case Studies
Figure Lung Cancer Case Studies
Figure Others Case Studies
Figure Non-invasive Cancer Diagnosis Report Years Considered
Table Global Non-invasive Cancer Diagnosis Market Size 2013-2025 (Million US$)
Figure Global Non-invasive Cancer Diagnosis Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Non-invasive Cancer Diagnosis Market Size by Regions 2013-2025 (Million US$)
Table Global Non-invasive Cancer Diagnosis Market Size by Regions 2013-2018 (Million US$)
Table Global Non-invasive Cancer Diagnosis Market Share by Regions 2013-2018
Figure Global Non-invasive Cancer Diagnosis Market Share by Regions 2013-2018
Figure Global Non-invasive Cancer Diagnosis Market Share by Regions 2018
Table Market Top Trends
Table Global Non-invasive Cancer Diagnosis Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Non-invasive Cancer Diagnosis Market Share by Manufacturers (2013-2018)
Figure Global Non-invasive Cancer Diagnosis Market Share by Manufacturers in 2018
Table Global Non-invasive Cancer Diagnosis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Non-invasive Cancer Diagnosis Product/Solution/Service
Table Date of Enter into Non-invasive Cancer Diagnosis Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Non-invasive Cancer Diagnosis Market Size by Type (2013-2018) (Million US$)
Table Global Non-invasive Cancer Diagnosis Market Size Share by Type (2013-2018)
Figure Global Non-invasive Cancer Diagnosis Market Size Market Share by Type (2013-2018)
Table Global Non-invasive Cancer Diagnosis Market Size by Application (2013-2018) (Million US$)
Table Global Non-invasive Cancer Diagnosis Market Size Share by Application (2013-2018)
Figure Global Non-invasive Cancer Diagnosis Market Size Market Share by Application (2013-2018)
Figure Global Non-invasive Cancer Diagnosis Revenue Market Share by Application in 2017
Figure United States Non-invasive Cancer Diagnosis Market Size 2013-2018 (Million US$)
Table United States Key Players Non-invasive Cancer Diagnosis Revenue (2017-2018) (Million US$)
Table United States Key Players Non-invasive Cancer Diagnosis Market Share (2017-2018)
Table United States Non-invasive Cancer Diagnosis Market Size by Type (2013-2018) (Million US$)
Table United States Non-invasive Cancer Diagnosis Market Share by Type (2013-2018)
Table United States Non-invasive Cancer Diagnosis Market Size by Application (2013-2018) (Million US$)
Table United States Non-invasive Cancer Diagnosis Market Share by Application (2013-2018)
Figure Europe Non-invasive Cancer Diagnosis Market Size 2013-2018 (Million US$)
Table Europe Key Players Non-invasive Cancer Diagnosis Revenue (2017-2018) (Million US$)
Table Europe Key Players Non-invasive Cancer Diagnosis Market Share (2017-2018)
Table Europe Non-invasive Cancer Diagnosis Market Size by Type (2013-2018) (Million US$)
Table Europe Non-invasive Cancer Diagnosis Market Share by Type (2013-2018)
Table Europe Non-invasive Cancer Diagnosis Market Size by Application (2013-2018) (Million US$)
Table Europe Non-invasive Cancer Diagnosis Market Share by Application (2013-2018)
Figure China Non-invasive Cancer Diagnosis Market Size 2013-2018 (Million US$)
Table China Key Players Non-invasive Cancer Diagnosis Revenue (2017-2018) (Million US$)
Table China Key Players Non-invasive Cancer Diagnosis Market Share (2017-2018)
Table China Non-invasive Cancer Diagnosis Market Size by Type (2013-2018) (Million US$)
Table China Non-invasive Cancer Diagnosis Market Share by Type (2013-2018)
Table China Non-invasive Cancer Diagnosis Market Size by Application (2013-2018) (Million US$)
Table China Non-invasive Cancer Diagnosis Market Share by Application (2013-2018)
Figure Japan Non-invasive Cancer Diagnosis Market Size 2013-2018 (Million US$)
Table Japan Key Players Non-invasive Cancer Diagnosis Revenue (2017-2018) (Million US$)
Table Japan Key Players Non-invasive Cancer Diagnosis Market Share (2017-2018)
Table Japan Non-invasive Cancer Diagnosis Market Size by Type (2013-2018) (Million US$)
Table Japan Non-invasive Cancer Diagnosis Market Share by Type (2013-2018)
Table Japan Non-invasive Cancer Diagnosis Market Size by Application (2013-2018) (Million US$)
Table Japan Non-invasive Cancer Diagnosis Market Share by Application (2013-2018)
Figure Southeast Asia Non-invasive Cancer Diagnosis Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Non-invasive Cancer Diagnosis Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Non-invasive Cancer Diagnosis Market Share (2017-2018)
Table Southeast Asia Non-invasive Cancer Diagnosis Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Non-invasive Cancer Diagnosis Market Share by Type (2013-2018)
Table Southeast Asia Non-invasive Cancer Diagnosis Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Non-invasive Cancer Diagnosis Market Share by Application (2013-2018)
Figure India Non-invasive Cancer Diagnosis Market Size 2013-2018 (Million US$)
Table India Key Players Non-invasive Cancer Diagnosis Revenue (2017-2018) (Million US$)
Table India Key Players Non-invasive Cancer Diagnosis Market Share (2017-2018)
Table India Non-invasive Cancer Diagnosis Market Size by Type (2013-2018) (Million US$)
Table India Non-invasive Cancer Diagnosis Market Share by Type (2013-2018)
Table India Non-invasive Cancer Diagnosis Market Size by Application (2013-2018) (Million US$)
Table India Non-invasive Cancer Diagnosis Market Share by Application (2013-2018)
Figure Central & South America Non-invasive Cancer Diagnosis Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Non-invasive Cancer Diagnosis Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Non-invasive Cancer Diagnosis Market Share (2017-2018)
Table Central & South America Non-invasive Cancer Diagnosis Market Size by Type (2013-2018) (Million US$)
Table Central & South America Non-invasive Cancer Diagnosis Market Share by Type (2013-2018)
Table Central & South America Non-invasive Cancer Diagnosis Market Size by Application (2013-2018) (Million US$)
Table Central & South America Non-invasive Cancer Diagnosis Market Share by Application (2013-2018)
Table Gen-Probe Inc. Company Details
Table Gen-Probe Inc. Revenue in Non-invasive Cancer Diagnosis Business (2013-2018) (Million US$)
Figure Gen-Probe Inc. Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2013-2018)
Table Gen-Probe Inc. Recent Development
Table A&G Pharmaceutical Company Details
Table A&G Pharmaceutical Revenue in Non-invasive Cancer Diagnosis Business (2013-2018)(Million US$)
Figure A&G Pharmaceutical Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2013-2018)
Table A&G Pharmaceutical Recent Development
Table Affymetrix Inc. Company Details
Table Affymetrix Inc. Revenue in Non-invasive Cancer Diagnosis Business (2013-2018)(Million US$)
Figure Affymetrix Inc. Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2013-2018)
Table Affymetrix Inc. Recent Development
Table Digene Corporation Company Details
Table Digene Corporation Revenue in Non-invasive Cancer Diagnosis Business (2013-2018)(Million US$)
Figure Digene Corporation Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2013-2018)
Table Digene Corporation Recent Development
Table Quest Diagnostics Inc. Company Details
Table Quest Diagnostics Inc. Revenue in Non-invasive Cancer Diagnosis Business (2013-2018)(Million US$)
Figure Quest Diagnostics Inc. Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2013-2018)
Table Quest Diagnostics Inc. Recent Development
Table BioView Inc. Company Details
Table BioView Inc. Revenue in Non-invasive Cancer Diagnosis Business (2013-2018)(Million US$)
Figure BioView Inc. Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2013-2018)
Table BioView Inc. Recent Development
Table LabCorp Company Details
Table LabCorp Revenue in Non-invasive Cancer Diagnosis Business (2013-2018)(Million US$)
Figure LabCorp Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2013-2018)
Table LabCorp Recent Development
Table AVIVA Biosciences Corporation Company Details
Table AVIVA Biosciences Corporation Revenue in Non-invasive Cancer Diagnosis Business (2013-2018)(Million US$)
Figure AVIVA Biosciences Corporation Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2013-2018)
Table AVIVA Biosciences Corporation Recent Development
Table Precision Therapeutics Company Details
Table Precision Therapeutics Revenue in Non-invasive Cancer Diagnosis Business (2013-2018)(Million US$)
Figure Precision Therapeutics Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2013-2018)
Table Precision Therapeutics Recent Development
Table Global Non-invasive Cancer Diagnosis Market Size by Regions (Million US$) 2018-2025
Figure Global Non-invasive Cancer Diagnosis Market Size Share by Regions (2018-2025)
Figure Global Non-invasive Cancer Diagnosis Market Size Share by Regions in 2025
Figure United States Non-invasive Cancer Diagnosis Market Size Forecast (2018-2025)(Million USD)
Figure Europe Non-invasive Cancer Diagnosis Market Size Forecast (2018-2025)(Million USD)
Figure China Non-invasive Cancer Diagnosis Market Size Forecast (2018-2025)(Million USD)
Figure Japan Non-invasive Cancer Diagnosis Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Non-invasive Cancer Diagnosis Market Size Forecast (2018-2025)(Million USD)
Figure India Non-invasive Cancer Diagnosis Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Non-invasive Cancer Diagnosis Market Size Forecast (2018-2025)(Million USD)
Table Global Non-invasive Cancer Diagnosis Market Size by Product (2018-2025) (Million US$)
Figure Global Non-invasive Cancer Diagnosis Market Size by Product (2018-2025)
Figure Global Non-invasive Cancer Diagnosis Market Size by Product in 2025
Table Global Non-invasive Cancer Diagnosis Market Size by Application (2018-2025) (Million US$)
Figure Global Non-invasive Cancer Diagnosis Market Size by Application (2018-2025)
Figure Global Non-invasive Cancer Diagnosis Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Request Sample

* mark fields are compulsory